This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tousoulis, D. Articles by Toutouzas, P. Search for Related Content PubMed PubMed Citation Articles by Tousoulis, D. Articles by Toutouzas, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE NITRIC OXIDE Social Bookmarking                         What's this?

L-Arginine in cardiovascular disease: dream or reality?

Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece, Drtousoulis{at}hotmail.com

Charalambos Antoniades

Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece

Costas Tentolouris

Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece

George Goumas

Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece

Christodoulos Stefanadis

Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece

Pavlos Toutouzas

Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece

l-arginine is the substrate for endothelial nitric oxide synthase (eNOS), and the precursor for the synthesis of nitric oxide (NO). This amino acid exerts a number of actions in the cardiovascular system, mainly through the production of NO. However, it also has a number of NO-independent properties, such as the ability to regulate blood and intracellular pH and the effect on the depolarization of endothelial cell membranes. It also has antihypertensive and antioxidant properties, it influences blood viscosity and the coagulation/fibrinolysis system, and it affects the metabolism of glucose, lipids and proteins. L-arginine influences a number of atherosclerosis risk factors such as hypercholesterolemia, hypertension and smoking, improving endothelial function in these patients. However, it does not affect endothelial function in patients with diabetes mellitus. The role of L-arginine in coronary artery disease is still controversial, but it seems that oral or parenteral administration of this amino acid restores endothelial function in the brachial artery and improves coronary microcirculation. The role of L-arginine in heart failure is currently under investigation, and the first results are rather hopeful. In conclusion, L-arginine seems to provide a hopeful prospect for the treatment of cardiovascular diseases. However, more data derived from large-scale prospective studies evaluating the effects of long-term treatment with L-arginine are needed.

Key Words: L-arginine • atherosclerosis • coronary artery disease • endothelial function • heart failure

Vascular Medicine, Vol. 7, No. 3, 203-211 (2002)
DOI: 10.1191/1358863x02vm434ra


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Antoniades, C. Shirodaria, P. Leeson, A. Antonopoulos, N. Warrick, T. Van-Assche, C. Cunnington, D. Tousoulis, R. Pillai, C. Ratnatunga, et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis Eur. Heart J., May 1, 2009; 30(9): 1142 - 1150. [Abstract] [Full Text] [PDF]

				N. W. Rajapakse, C. De Miguel, S. Das, and D. L. Mattson Exogenous L-Arginine Ameliorates Angiotensin II-Induced Hypertension and Renal Damage in Rats Hypertension, December 1, 2008; 52(6): 1084 - 1090. [Abstract] [Full Text] [PDF]

				X. Jiang, F. Yang, H. Tan, D. Liao, R. M. Bryan Jr, J. K. Randhawa, R. E. Rumbaut, W. Durante, A. I. Schafer, X. Yang, et al. Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2515 - 2521. [Abstract] [Full Text] [PDF]

				C. Zhang, T. W. Hein, W. Wang, M. W. Miller, T. W. Fossum, M. M. McDonald, J. D. Humphrey, and L. Kuo Upregulation of Vascular Arginase in Hypertension Decreases Nitric Oxide-Mediated Dilation of Coronary Arterioles Hypertension, December 1, 2004; 44(6): 935 - 943. [Abstract] [Full Text] [PDF]